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Palladium Catalyzed Chloroethoxylation of Aromatic and 
Heteroaromatic Chlorides: an Orthogonal Functionalization of 
Chloroethoxy Linker† 
Bálint Pethő,a Dóra Vangel,a János T. Csenki,a Márton Zwillinger,a and Zoltán Novák*a
 
A novel disconnection based on cross-coupling chemistry was designed to access pharmaceutically relevant aryl-
aminoethyl ethers. The developed palladium-catalyzed functionalization of aryl- and heteroaryl chlorides with sodium 
tetrakis-(2-chloroethoxy)-borate salt is orthogonal to the simple nucleophilic replacement of the chloro function of the 
ethylene linker. The transformation enables efficient 2-chloroethoxylation in the absence of additional external base. 
Subsequent amine substitution of the alkyl halide affords 2-aminoethoxy arenes. The applicability of this method was 
demonstrated through the synthesis of various aryl- and heteroaryl-alkyl ethers, including intermediates of marketed drug 
molecules.
Introduction 
Orthogonality is a key aspect of molecular constructions in 





 for the access of crosslinked 
functional groups is strategically important, but its efficient 
execution encounters difficulties when reaction centers of the 
linker have similar properties or could interact under the 
reactions conditions. To circumvent these synthetic problems, 
novel orthogonal methods should be developed. Transition 
metal catalyzed cross-coupling reactions are one of the most 
powerful tools for the selective functionalization of various 
molecular scaffolds through the formation of new carbon-
carbon and carbon-heteroatom bonds.
3
 With the aid of this 
methodology, a large pool of functional groups can be 
introduced into aromatic, heteroaromatic and even to acyclic 
systems with high efficiency. Thus, in pharmaceutical research 
the transition metal-catalyzed cross-coupling technology has 
widespread application.
4
 However, the functionalization of 
cheaper and more versatile aromatic chlorides with cross-
coupling chemistry
5
 often encounters difficulties, and requires 
special catalyst systems and reaction conditions. On the other 
hand, introduction of some molecular motifs can also be 
challenging with the aid of transition metal-catalyzed 
reactions. One example of this is the 2-haloethoxy group, 
because the transition metal catalyzed C-O bond formation 
between 2-haloalcohols and aryl chloride coupling partners is 
not feasible. 
 
Scheme 1. Examples of drug molecules having aminoalkoxy function 
In spite of the significant developments in the field of C-O 
bond forming cross-coupling reactions for the synthesis of aryl-
alkyl ethers,
6
 this approach remained an elusive 
transformation due to the presence of a nucleophilic oxygen 
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atom and a sensitive alkyl halide moiety in the same coupling 
partner. Thus, the necessity of rather strong external bases in 
the aforementioned C-O bond forming coupling reactions lead 
to the formation of different side products. Successful 
formation of aryl-alkyl ethers bearing halide leaving groups 
attached to the alkyl chain offers versatile transformation 
possibilities. The halogen can be readily replaced with 
heteroatom nucleophiles, such as amines to provide the 2-
aminoethoxy group, which can be found in many drug 
molecules and other bioactive compounds (Scheme 1).
7 
The construction of 2-aminoethoxy arenes is mostly based on 
the O-alkylation of phenol derivatives with the utilization of 
alkylene synthons with appropriate leaving groups.
8
 In case of 
sensitive and complex substrates, the Mitsunobu reaction of 2-
aminoalcohols and phenols is a viable option,
9
 and in special 
cases, addition reactions,
10
 or nucleophilic aromatic 
substitutions could also be applied.
11 
A successful example of 
the synthesis of aryl-aminoalkyl ethers through cross-coupling 
reactions was described by Buchwald and co-workers (Scheme 
2).
6g
 Although there are numerous remarkable aspects of this 
transformation, two important features remained unsolved. 
First, aryl-iodides were used as substrates, while the 
corresponding bromides or chlorides were inactive, and 
selective C-O bond forming reaction could only be achieved by 
longer alkyl linkers. 
 
Scheme 2. Cu-catalyzed aminoalkoxylation of aryl-iodides 
Thus, the objective of our research was the development of an 
efficient and selective catalytic method for the 2-
chloroethoxylation of aryl chlorides. With a subsequent 
substitution reaction, a wide variety of nucleophiles can be 
introduced to the aryl-chloroethyl ethers, granting a modular 
synthetic route to 2-aminoethoxy-arenes, which are precious 
targets of pharmaceutical research. With respect to this goal, 
the application of borate salt-based catalytic methods for the 
synthesis of aryl-alkyl ethers developed in our laboratory could 




The development of a new cross-coupling approach to 2-
chloroethoxylation offers an alternative disconnection and 
provides a new synthetic tool beyond the existing phenol-
based transformations to construct C-O bonds. This can be 
useful, when instability issues, tautomerism or economic 
reasons make the phenol-type starting material unavailable. 
Results and discussion, Experimental 
For the examination of the applicability of the palladium-
catalyzed C-O bond forming reaction between aryl chlorides 
and borate reagents, first we prepared a novel tetrakis(2-
chloroethoxy) borate salt from inexpensive starting materials: 
2-chloroethanol and NaBH4. The coupling of the borate salt 
with p-chloroacetophenone was then examined in tert-amyl 
alcohol at 100°C in the presence of Pd2dba3 catalyst with 
different phosphine ligands (Table 1). The study of the ligand 
effect revealed that bulky, dialkyl-biphenyl phosphines were 
generally appropriate ligands for the efficient coupling.  
Table 1. Study of ligand effect on the coupling reaction[a] 
 







1 2a CyJohnPhos 1 1 
2 2a  JohnPhos 24 63 
3 2a  BrettPhos 1 92 
4 2a XPhos 13 54 
5 2a Me4
t
BuXPhos 0 86 








BuXPhos complex mixture 45
[c, d]
 
[a] 0.1 mmol aryl chloride, 0.15 mmol Na[B(OCH2CH2Cl)4], 200 µL 
tAmyl-alcohol. 
[b] Determined by GC analysis after 1 h; numbers in parenthesis indicate 
conversions after 24 h. [c] Isolated yield. [d] 1.5 equiv of Cs2CO3 was used as base. 
Comparing the alkyl-substituents, ligands bearing tert-butyl 
groups were more active, than their cyclohexyl-substituted 
derivatives (entries 1 vs 2 and 4 vs. 7). Among the tested 
ligands 
t
BuXPhos proved to be the best choice with respect to 
both activity and economy. With its application, 100% 
conversion was reached in 1h, and after the workup the 
chloroethoxylated product 3a was isolated in 95% yield. To 
demonstrate the beneficial effect of borate coupling partners 
over simple alcohols, the preparation of the same product was 
attempted using the well-established reaction of 
chloroacetophenone and 2-chloroethanol in the presence of 
Cs2CO3.
 13
 This reaction gave a complex product mixture after 
complete consumption of the substrate, and the desired 
coupled product 3a was isolated only in 45% yield (entry 8). 
With the optimized reaction conditions in hand, we turned our 
attention to the applicability of the method in the synthesis of 
various aromatic and heteroaromatic 2-chloroethoxy 
derivatives (Scheme 3). The formyl group was tolerated well 
and coupling reaction through the chloro function in ortho-, 
meta-, and para-position to the aldehyde group was successful 
under the optimized reaction conditions, affording products 
3b-d in 79, 58 and 99% yield respectively. The coupling 
reaction took place smoothly in the presence of electron 
withdrawing groups such as nitro, cyano and trifluoromethyl, 
providing products 3e-g in 80-91% yield. 4-Chloro-
vinylbenzene was also chloroethoxylated, providing 3h in 77% 
yield. Electron donating groups such as methoxy- or MOM-
protected phenolic OH also enabled the cross-coupling on the 
chloride, however, the electron rich nature of the substrates 
resulted in lower reactivity. Products 3i and 3j were isolated in 
68% and 67% yield after the workup of the reaction mixture. A 
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notable limitation of the transformation occurred when the 
methoxy group was para to the chloro function; the 
conversion of the reaction reached only 10% (not shown), 
indicating that the electronic factors play a key role in the 
transformation.  
 
Scheme 3. Chloroethoxylation of aromatic chlorides 
To expand further the substrate scope of the coupling reaction 
we examined 2-chloro- and 5-chloroquinolines. These 
experiments showed that both the heterocyclic and the 
carbocyclic part of the ring could be functionalized in the 
palladium catalyzed reaction, and product 3k and 3l were 
isolated in 88% and 66% yields. Thienopyridines are important 
heterocyclic scaffolds in medicinal chemistry, therefore we 
examined the chloroethoxylation of the chloro derivative of 
this heterocycle. To our delight this special heterocyclic 
building block underwent smooth transformation and the 
target product 3m was isolated in 64% yield. 
After demonstrating of the applicability of the developed 
coupling for the synthesis of 2-chloroethoxylated building 
blocks, we extended the coupling with a subsequent 
substitution step to prepare aminoethoxy derivatives in a one-
pot manner (Scheme 4). Among the several well-known 
methods for this purpose, our choice was to keep it simple, 
utilizing the Finkelstein halogen exchange reaction followed by 
nucleophilic substitution with secondary amines in the 
presence of potassium iodide and potassium carbonate base. 
For the examination of the two step one-pot functionalization 
method we performed the palladium-catalyzed step on three 
different aryl chlorides previously chloroethoxylated. Then 
intermediates 3a, 3e and 3g were subjected to nucleophilic 
replacement of the chloro group with N-methylpiperazine and 
morpholine affording the aminoethoxylated products 4a-c in 
44-72% yield. For the further studies we used different aryl 
chlorides to expand the substrate scope of both the cross-
coupling step and the one-pot aminoalkoxylation strategy. 
Chlorobenzenes bearing formyl, nitro or ester group in the 
para-position were straightforwardly chloroethoxylated in the 
palladium-catalyzed transformation and then substituted with 
piperidine, diethylamine and N-methylmorpholine, affording 
products 4d-g in 71-88% yield. Compound 4h was obtained in 
73% yield in the two step procedure starting from 4-chloro-8-
trifluoromethyl-quinoline, with pyrrolidine being used as the  
 
Scheme 4. One-pot aminoethoxylation of chloroarenes 
amine nucleophile after the palladium-catalyzed 
chloroethoxylation step. The same strategy was used to 
prepare a highly electron-rich benzothiophene substrate, 
though a large amount of unreacted starting material was 
recovered beside the isolation of compound 4i as the desired 
aminoethoxylated product. 
To illustrate the applicability of this method, we carried out 
the synthesis of an analog and an intermediate of active 
pharmaceutical ingredients (Scheme 5) containing condensed 
heterocyclic cores such as indoles and benzothiophenes. First, 
we prepared the aryl-chloride substrate 5a through the N-
benzylation of indole with 4-chlorobenzyl-bromide,
14
 for the 
key aminoalkoxylation step.
 
Then the palladium-catalyzed 
coupling reaction with Na[B(OCH2CH2Cl)4] and subsequent 
amination under the developed reaction conditions led to a 
70% yield of the desired product 5b, which contains the core 
of the selective estrogen receptor modulator (SERM) drug,  
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Scheme 5. Synthesis of Bazedoxifene-analogue and the intermediate of 
Raloxifene 
Bazedoxifene. Another example to illustrate the applicability of 
our aminoalkoxylation method was the design of an 
alternative synthetic route to Raloxifene intermediate 6c. First, 
the Friedel-Crafts acylation of a commercially available 
benzothiophene-derivative (6a) was achieved,
15
 leading to the 
starting material (6b) equipped with chloro function necessary 
for the cross-coupling reaction. The 2-chloroethoxylation with 
the borate salt under the catalytic conditions and subsequent 
substitution step with piperidine afforded the desired 
Raloxifene intermediate (6c) in almost quantitative yield. 
Conclusions 
In conclusion, we have developed an alternative, simple and 
convenient synthetic route to the access of 2-chloroethoxy-
arenes using palladium-catalyzed cross-coupling reaction of 
aryl chlorides and tetraethoxyborates. This methodology is 
orthogonal to nucleophilic substitution and enables the 
modular synthesis of various molecules containing ethoxy 
linkers between nucleophilic centers (eg. amines) and aromatic 
cores. The utilization of a novel borate salt ensures efficient 
transformation with good functional group tolerance due to 
the absence of external base, and eliminates synthetic 
difficulties of the traditional alkoxylation with haloalcohols. 
This special feature of the transformation provides a new 
synthesis concept in the field of C-O bond forming reactions. 
With a subsequent simple nucleophilic substitution reaction 
step, wide variety of 2-aminoethoxy-arenes can be prepared in 
a one-pot manner. Beyond several aminoalkoxylated model 
compounds, the applicability of the two step one-pot reaction 
was demonstrated with the synthesis of a Bazedoxifene-
analogue and the final intermediate of Raloxifene. Thus, 
previously unavailable synthetic routes to bioactive molecules 
can be performed with the application of this method, which 
can be an alternative, efficient tool for generic and original 
pharmaceutical research. The new methodology paves the 
way for versatile alkoxylation reactions to the direct access of 
aryl-haloalkyl ethers which are susceptible for further 
transformations with various nucleophiles. 
Experimental 
General procedure for the 2-chloroethoxylation of 
chloroarenes: A 4 ml screw cap vial was charged with Pd2dba3 
(4.6 mg, 5,0 µmol, 1 mol%), 2-di-tert-butylphosphino-2′,4′,6′-
triisopropylbiphenyl (
t
BuXphos, 4.2 mg, 10.0 µmol, 2 mol%), 
the aryl chloride substrate (0.5 mmol, 1 equiv) and 100 µl tert-
amyl alcohol. The atmosphere was changed to argon, then the 
suspension of sodium tetrakis(2-chloroethoxy) borate in 900 µl 
tert-amyl alcohol was added via syringe, and stirring started at 
100 °C, usually for one hour. When the reaction was complete, 
the mixture was diluted with brine (10 ml) and extracted with 
EtOAc (3*15 ml). The combined organic layers were 
evaporated and purified by column chromatography. 
 
General procedure for the one-pot synthesis of 2-
aminoethoxy arenes: A 4 ml screw-cap vial equipped with a 
stirring bar was charged with Pd2dba3 (4.6 mg, 5 µmol, 1.0 
mol%), 
t
BuXPhos (4.2 mg, 10 µmol, 2.0 mol%) the substrate if 
solid (0.5 mmol, 1 equiv), and tert-amyl alcohol (100 µl). The 
atmosphere was changed to argon, and the solution was 
stirred at RT for 5 minutes. The suspension of 
Na[B(OCH2CH2Cl)4] (263.9 mg, 0.75 mmol, 1.5 equiv) in tert-
amyl alcohol (900 µl), and the substrate (0.5 mmol) if liquid 
was added and the mixture was stirred at 100 °C for 1-24 
hours. The mixture was allowed to cool down to room 
temperature, KI (166 mg, 1 mmol, 2 equiv), K2CO3 (138 mg, 1 
mmol, 2 equiv) and secondary amine (eg.: piperidine, 2 ml) 
was added to the solution, then stirred at 100 °C for further 4-
24 hours. The mixture was cooled down to room temperature, 
diluted with water (10 ml), and extracted with EtOAc (3X15 
ml). The combined organic layers were evaporated under 
reduced pressure, and purified by column chromatography 
(silica gel, DCM:MeOH eluent mixture). 
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